🇺🇸 FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12213996

Methods of treating optic nerve diseases using neural progenitor cell growth factors

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11827683

Bi-functional anti-tau polypeptides and use thereof

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11072639

Bi-functional anti-tau polypeptides and use thereof

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10369192

Methods and compositions for delivery of exogenous factors to nervous system sites

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10034916

Methods of treating a retinal disease by retinal pigment epithelial stem cells

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481313

Retinal pigment epithelial stem cells

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted